Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
作者信息
Golwala Harsh, Bajaj Navkaranbir Singh, Arora Garima, Arora Pankaj
机构信息
From Brigham and Women's Heart and Vascular Institute, Boston, MA (H.G., N.S.B.); Division of Cardiovascular Diseases, University of Alabama, Birmingham (N.S.B., G.A., P.A.); and Section of Cardiology, Birmingham Veterans Affairs Medical Center, AL (P.A.).
出版信息
Circulation. 2017 Jun 20;135(25):e1200-e1202. doi: 10.1161/CIRCULATIONAHA.117.028200.
Abstract
摘要
相似文献
1
Response by Golwala et al to Letter Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
Circulation. 2017 Jun 20;135(25):e1200-e1202. doi: 10.1161/CIRCULATIONAHA.117.028200.
2
Letter by Nery et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
Circulation. 2017 Jun 20;135(25):e1198-e1199. doi: 10.1161/CIRCULATIONAHA.117.027389.
3
Letter by Barakat et al Regarding Article, "Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis".
Circulation. 2017 Jun 20;135(25):e1196-e1197. doi: 10.1161/CIRCULATIONAHA.116.027106.
4
Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.
Circulation. 2017 Jan 10;135(2):201-203. doi: 10.1161/CIRCULATIONAHA.116.026056. Epub 2016 Dec 19.
5
Response by Jablonowski et al to Letter Regarding Article, "Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods".
Circ Cardiovasc Imaging. 2018 Jan;11(1):e007333. doi: 10.1161/CIRCIMAGING.117.007333.
6
Letter by Guaricci et al Regarding Article, "Cardiovascular Magnetic Resonance to Predict Appropriate Implantable Cardioverter Defibrillator Therapy in Ischemic and Nonischemic Cardiomyopathy Patients Using Late Gadolinium Enhancement Border Zone: Comparison of Four Analysis Methods".
Circ Cardiovasc Imaging. 2018 Jan;11(1):e007213. doi: 10.1161/CIRCIMAGING.117.007213.
7
Implantable Cardioverter Defibrillator for the Primary Prevention of Sudden Cardiac Death in Patients With Nonischemic Cardiomyopathy.
Angiology. 2018 Apr;69(4):297-302. doi: 10.1177/0003319717710851. Epub 2017 May 30.
8
Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis.
Cardiovasc Ther. 2017 Jun;35(3). doi: 10.1111/1755-5922.12253.
9
Use of the wearable cardioverter defibrillator in high-risk cardiac patients: data from the Prospective Registry of Patients Using the Wearable Cardioverter Defibrillator (WEARIT-II Registry).
Circulation. 2015 Oct 27;132(17):1613-9. doi: 10.1161/CIRCULATIONAHA.115.015677. Epub 2015 Aug 27.
10
Response by Elming et al to Letter Regarding Article, "Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure".
Circulation. 2018 May 15;137(20):2190. doi: 10.1161/CIRCULATIONAHA.118.033772.
本文引用的文献
1
Implantable Cardioverter-Defibrillator for Nonischemic Cardiomyopathy: An Updated Meta-Analysis.
Circulation. 2017 Jan 10;135(2):201-203. doi: 10.1161/CIRCULATIONAHA.116.026056. Epub 2016 Dec 19.
2
Conducting and interpreting high-quality systematic reviews and meta-analyses.
J Nucl Cardiol. 2017 Apr;24(2):471-481. doi: 10.1007/s12350-016-0598-9. Epub 2016 Aug 2.
3
Outcomes of elderly heart failure recipients of ICD and CRT.
Int J Cardiol. 2008 Apr 10;125(2):154-60. doi: 10.1016/j.ijcard.2007.10.007. Epub 2007 Oct 31.
4
Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.
N Engl J Med. 2005 Jan 20;352(3):225-37. doi: 10.1056/NEJMoa043399.
5
Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
JAMA. 2004 Dec 15;292(23):2874-9. doi: 10.1001/jama.292.23.2874.
6
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
N Engl J Med. 2004 May 20;350(21):2140-50. doi: 10.1056/NEJMoa032423.
7
The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials.
J Clin Epidemiol. 1997 Jun;50(6):683-91. doi: 10.1016/s0895-4356(97)00049-8.
Zotero 插件